Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Pound firms, lifted by soothing Omicron news, higher gilt yields

Thu, 23rd Dec 2021 11:24

(Updates throughout, adds chart, quotes)

By Sujata Rao

LONDON, Dec 23 (Reuters) - Sterling rose to one-month highs
against the dollar and euro on Thursday, benefiting from some
reassuring reports on the Omicron COVID-19 variant and a move
higher in Britain's short-dated government bond yields.

A three-dose course of AstraZeneca's COVID-19
vaccine is effective against Omicron, the company said, citing
data from an Oxford University study. Its findings match those
from rivals Pfizer-BioNTech and Moderna, which say a third shot
of their vaccines works against Omicron.

Coming on top of reports that Omicron patients are less
likely to need hospitalisation, the news raised hopes that
governments may not need to widen restrictions on activities,
allowing economies to recover.

Britain also cut its COVID-19 self-isolation period to seven
days from 10 days for those who test negative two days in a row.

UK businesses posted the weakest quarterly growth since the
three months to April when lockdowns were in effect, the
Confederation of British Industry (CBI) said.

By 1030 GMT, the pound rose 0.4% to the dollar at $1.3380,
just off a one-month peak of $1.33875 hit earlier.
Against the euro, it firmed to the highest in a month, up 0.4%
to 84.45 pence.

UK gilt yields rose too, outstripping German and U.S. peers,
with 10-year yields up 4.5 basis points and two-year yields
hitting the highest since early November.

Nomura strategist Jordan Rochester noted a pickup in UK
"real" or inflation-adjusted yields. British 5-year real yields
are up some 60 basis points since mid-December. while its U.S.
and German counterparts have flatlined, Refinitiv data shows,

"If you're looking for why sterling remains bid, it's the
continued pickup in real yields," Rochester said, though he
suggested the moves were attributed more to Christmas volumes
"rather than the start of a new uptrend" with the positive
impulse from BOE rate hikes already largely priced in.

Money markets are factoring in 100 basis points of rate
hikes from the BOE in 2022 but Rochester noted headwinds to UK
growth from soaring gas prices and full EU customs controls
kicking in from Jan. 1.

The pound has risen 1.6% to the dollar since Dec. 15, just
before a surprise Bank of England interest rate hike.

Societe Generale analysts said the latest pound gains had
also kicked off as the dollar failed to break above $1.32 on
Wednesday, triggered short-covering.

More positive Omicron news may be needed to fuel further
significant moves, they added.

(Reporting by Sujata Rao; Editing by Catherine Evans and
Bernadette Baum)

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.